Merger

National Bank Holdings Corp. finalizes its acquisition of Vista Bank, creating a $12.6B regional power and expanding into high-growth Texas and Florida markets.

Alerus Financial is set to release its Q4 results, capping a year of strategic growth. Investors watch to see if its unique model can sustain momentum.

Rumble moves forward with its transformative Northern Data acquisition, aiming for AI dominance, but a major tax fraud probe in Europe looms over the deal.

Ervin Cohen & Jessup merges with Carico McDonald Kil & Benz, adding a top-tier team and a new Beach Cities office to bolster its West Coast presence.

A new report highlights explosive growth in tokenized stocks, with platforms like Bitget's Universal Exchange leading the charge to merge crypto and TradFi.

Mackenzie Investments' 2026 forecast warns of fewer Fed cuts than expected, highlighting opportunities in AI-driven equities and strategic commodities.

Main Street Capital realizes a massive gain from its Mystic Logistics exit and reinvests to merge it with UBM, creating a powerhouse in marketing mail.

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

Prenetics slashed future dilution risk by exchanging 4.7M warrants, a move analysts see as crucial for fueling the rapid growth of its IM8 wellness brand.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.

Patria Investments' major acquisition of CLO specialist Solis Investimentos signals a new era for private credit in Latin America's evolving market.

The Baldwin Group finalizes its mega-merger with CAC Group, creating a new powerhouse with over $2B in projected revenue and deep specialty expertise.

The specialty insurer's acquisition of Apollo is set to add over $1.5B in managed premiums, provide a strategic entry into Lloyd's, and boost tech.

Lantheus sells its legacy SPECT business to fusion-tech firm SHINE, sharpening its focus on high-growth PET diagnostics and next-gen cancer therapies.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

Chinese auto giant GAC nearly tripled its exports in two years. Its secret? A hyper-localized strategy that is challenging incumbents worldwide.

As Aircastle prepares its Q3 2025 results, all eyes are on the leasing giant for insights into the supercharged global aviation finance sector.

As Equity Bancshares preps its Q4 report, investors eye its M&A success, margin health, and 2026 guidance amid a complex economic landscape.

Inszone Insurance continues its rapid expansion by acquiring a 50-year-old agency, gaining deep expertise in the booming event and specialty insurance market.